International net sales grew by 12 percent to approximately $104 million, while U.S. net sales increased by 2 percent to $426.3 million. The company reported strong growth in its sports, extremities and trauma businesses, at 13 percent overall. Hip sales also increased by 7 percent worldwide.
However, the company’s spine and bone healing sales decreased by 5 percent worldwide. The company also reported a decrease in “other” products and biologics, which was offset by sales growth in the microfixation business.
Related Articles on Orthopedic Devices:
Amp Orthopedics Initiates Knee & Shoulder Device Clinical Trials
K2M Names Don O’Hearn Senior Vice President of Sales in Americas
39 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in November
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.